Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
about
Modern brain tumor imagingThe role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectivesRecent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma PatientsPerfusion MRI: the five most frequently asked clinical questions.Magnetic resonance perfusion imaging in neuro-oncology.Lesions masquerading as acute stroke.3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.Imaging of brain metastasesMeasurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Imaging biomarkers in primary brain tumours.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Morphometric model for discrimination between glioblastoma multiforme and solitary metastasis using three-dimensional shape analysis.Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors.Advanced MR imaging in hemispheric low-grade gliomas before surgery; the indications and limits in the pediatric age.Metastasis in Adult Brain Tumors.Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.Perilesional Hyperintensity on T1-Weighted Images in Intra-Axial Brain Masses other than Cavernous Malformations.Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imagingGlioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imagingClinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma.Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications.Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumoursRegional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma ModelRelative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.Current Clinical Brain Tumor ImagingImpact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.Controversies in the management of brain metastasesA prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBMDifferentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patientsRadiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence
P2860
Q27002344-3BA025D4-ED6A-4AFD-BB70-47F6193F6FC0Q27021359-B1D19FAF-221A-48E5-82D8-A9AE1745843DQ28066044-FEFA3032-9A28-49AB-9470-8A3124065041Q30416198-A6437854-2787-4899-84AA-F2E1615B9910Q30479156-47A7C55E-C4C7-48B5-B98D-E2B835B4AEA4Q30582481-E0731B30-192D-4550-94DF-9CDE77A16AE1Q30587309-15F23F4F-1373-4159-8E30-69A8FAE7BF67Q30635460-F8401EEA-694D-4C1B-AF0A-DDE39951382EQ30653828-4CB833A2-1759-46AB-8D98-4AF37DCC4555Q30872679-B476A598-2D8E-485E-AF9F-2C67E162509FQ30880129-5172C63C-993E-4E1B-8AB9-C07BC3ED4D3DQ30938805-173C8E9C-D1E7-4EA8-9802-098E271A439CQ30980326-713A9191-30A7-425B-9680-FB56F89B4684Q31022764-DAA7B42E-7003-4921-B86F-BDCD0419A3E3Q31132595-1A7CEEA5-1E21-45D5-9FAC-99B275EB3E44Q31135280-B1818C82-D68A-4F42-9F3E-D84102DD2DBAQ31143153-A46E3B1A-615C-471D-85AC-9FA09AF476A7Q31155220-E09DFE20-C2B1-42F9-A7F2-E8B6F3ECBE27Q33507482-0836974A-0C9B-4751-AEAE-C3EF355122A2Q33525779-A14BA69C-B38A-414E-ADE1-9E2D5E6A894FQ34011150-94E6AEFC-6C5C-4027-91D9-27569F73FAB8Q34050020-41D72A1B-C35E-4C97-A8A4-7C9EB7D3CD63Q34203930-FEEC3ABD-C041-41FF-B781-B6AF94B595CAQ34389144-07A959D7-07CD-408A-92DD-9A2DE252341BQ34498046-19B13792-1820-4D8F-9E0D-7179BD863259Q34498073-E715B8A6-7DEC-49C4-ABFA-0FB61D650A6DQ35047706-97A70943-FAA5-48D4-95F5-074FAC0E4A92Q35170356-CA8B192B-821E-4873-BCC4-744D6800DC82Q35811181-3A5614F8-0B3A-4A10-908B-8FF866FD71D8Q36048224-02F736DD-C81C-4F10-8A6C-C41112990B6DQ36231584-0527F44F-83E9-46E3-B2E6-0F1487105BA7Q36295701-9C0B3735-96B3-46D6-B06C-C0B2DA9C8ED5Q36367172-D5FC626C-C578-4284-A3A2-C9493676AD32Q36378153-4ADB3DE0-338A-42F2-A22A-B4EBE5911C16Q36851177-8D75F0DE-FB7C-4CC8-A5FD-DDDE1E4FC4C3Q36893250-76A74771-DCF4-47FE-949E-74E0B13CAD1DQ37014722-A86B6074-988E-4AC6-835D-20527A918928Q37127193-7D45A106-159C-4D7C-89C8-995FD9CEA9DEQ37212449-C5AC871E-625E-41A2-BF63-FFAE9AC54A00Q37233933-FF1BBB3D-782F-433A-82A0-BC56AA357ABC
P2860
Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@en
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@nl
type
label
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@en
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@nl
prefLabel
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@en
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@nl
P2093
P356
P1476
Differentiation of glioblastom ...... enhanced perfusion MR imaging.
@en
P2093
Lamborn KR
McDermott MW
P304
P356
10.3174/AJNR.A0484
P577
2007-06-01T00:00:00Z